ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vaccin Antirabic Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-13S7968
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Vaccin Antirabic Market Insights and Forecast to 2028
BUY CHAPTERS

Global Vaccin Antirabic Market Research Report 2025

Code: QYRE-Auto-13S7968
Report
July 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GSK
Sanofi
Chengda
Yisheng
Merck
VACN
Changsheng
BCHT
Hissen
Zhongke Biological
Ningbo Rongan Biological Pharmaceutical
Guangzhou Nuocheng Biological

Vaccin Antirabic Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Vaccin Antirabic Market

Vaccin Antirabic Market

The global market for Vaccin Antirabic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Rabies vaccine is a vaccine to prevent the occurrence of rabies.The vaccine is very good at preventing wound infection.It can be divided into two types: one is post-exposure (bite, scratch) prevention, and the other is pre-exposure (no bite, scratch) prevention.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vaccin Antirabic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccin Antirabic.
The Vaccin Antirabic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaccin Antirabic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccin Antirabic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Vaccin Antirabic Market Report

Report Metric Details
Report Name Vaccin Antirabic Market
CAGR 5%
Segment by Type
Segment by Application
  • Pre-exposure Prophylaxis
  • After Exposure Prophylaxis
  • Additional Doses
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK, Sanofi, Chengda, Yisheng, Merck, VACN, Changsheng, BCHT, Hissen, Zhongke Biological, Ningbo Rongan Biological Pharmaceutical, Guangzhou Nuocheng Biological
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Vaccin Antirabic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Vaccin Antirabic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Vaccin Antirabic Market report?

Ans: The main players in the Vaccin Antirabic Market are GSK, Sanofi, Chengda, Yisheng, Merck, VACN, Changsheng, BCHT, Hissen, Zhongke Biological, Ningbo Rongan Biological Pharmaceutical, Guangzhou Nuocheng Biological

What are the Application segmentation covered in the Vaccin Antirabic Market report?

Ans: The Applications covered in the Vaccin Antirabic Market report are Pre-exposure Prophylaxis, After Exposure Prophylaxis, Additional Doses

What are the Type segmentation covered in the Vaccin Antirabic Market report?

Ans: The Types covered in the Vaccin Antirabic Market report are Gopher Kidney Cell Vaccine, Freeze-Dried Vero Cell Vaccine, Common Vero Cell Vaccines, Human Diploid Vaccine

Recommended Reports

Human Vaccines

Infectious Disease Drugs

Vaccine Devices & Delivery

1 Vaccin Antirabic Market Overview
1.1 Product Definition
1.2 Vaccin Antirabic by Type
1.2.1 Global Vaccin Antirabic Market Value Comparison by Type (2024 VS 2031)
1.2.2 Gopher Kidney Cell Vaccine
1.2.3 Freeze-Dried Vero Cell Vaccine
1.2.4 Common Vero Cell Vaccines
1.2.5 Human Diploid Vaccine
1.3 Vaccin Antirabic by Application
1.3.1 Global Vaccin Antirabic Market Value by Application (2024 VS 2031)
1.3.2 Pre-exposure Prophylaxis
1.3.3 After Exposure Prophylaxis
1.3.4 Additional Doses
1.4 Global Vaccin Antirabic Market Size Estimates and Forecasts
1.4.1 Global Vaccin Antirabic Revenue 2020-2031
1.4.2 Global Vaccin Antirabic Sales 2020-2031
1.4.3 Global Vaccin Antirabic Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vaccin Antirabic Market Competition by Manufacturers
2.1 Global Vaccin Antirabic Sales Market Share by Manufacturers (2020-2025)
2.2 Global Vaccin Antirabic Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Vaccin Antirabic Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Vaccin Antirabic, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccin Antirabic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccin Antirabic, Product Type & Application
2.7 Global Key Manufacturers of Vaccin Antirabic, Date of Enter into This Industry
2.8 Global Vaccin Antirabic Market Competitive Situation and Trends
2.8.1 Global Vaccin Antirabic Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Vaccin Antirabic Players Market Share by Revenue
2.8.3 Global Vaccin Antirabic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vaccin Antirabic Market Scenario by Region
3.1 Global Vaccin Antirabic Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Vaccin Antirabic Sales by Region: 2020-2031
3.2.1 Global Vaccin Antirabic Sales by Region: 2020-2025
3.2.2 Global Vaccin Antirabic Sales by Region: 2026-2031
3.3 Global Vaccin Antirabic Revenue by Region: 2020-2031
3.3.1 Global Vaccin Antirabic Revenue by Region: 2020-2025
3.3.2 Global Vaccin Antirabic Revenue by Region: 2026-2031
3.4 North America Vaccin Antirabic Market Facts & Figures by Country
3.4.1 North America Vaccin Antirabic Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vaccin Antirabic Sales by Country (2020-2031)
3.4.3 North America Vaccin Antirabic Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vaccin Antirabic Market Facts & Figures by Country
3.5.1 Europe Vaccin Antirabic Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vaccin Antirabic Sales by Country (2020-2031)
3.5.3 Europe Vaccin Antirabic Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccin Antirabic Market Facts & Figures by Region
3.6.1 Asia Pacific Vaccin Antirabic Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vaccin Antirabic Sales by Region (2020-2031)
3.6.3 Asia Pacific Vaccin Antirabic Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vaccin Antirabic Market Facts & Figures by Country
3.7.1 Latin America Vaccin Antirabic Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vaccin Antirabic Sales by Country (2020-2031)
3.7.3 Latin America Vaccin Antirabic Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccin Antirabic Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccin Antirabic Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vaccin Antirabic Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vaccin Antirabic Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccin Antirabic Sales by Type (2020-2031)
4.1.1 Global Vaccin Antirabic Sales by Type (2020-2025)
4.1.2 Global Vaccin Antirabic Sales by Type (2026-2031)
4.1.3 Global Vaccin Antirabic Sales Market Share by Type (2020-2031)
4.2 Global Vaccin Antirabic Revenue by Type (2020-2031)
4.2.1 Global Vaccin Antirabic Revenue by Type (2020-2025)
4.2.2 Global Vaccin Antirabic Revenue by Type (2026-2031)
4.2.3 Global Vaccin Antirabic Revenue Market Share by Type (2020-2031)
4.3 Global Vaccin Antirabic Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vaccin Antirabic Sales by Application (2020-2031)
5.1.1 Global Vaccin Antirabic Sales by Application (2020-2025)
5.1.2 Global Vaccin Antirabic Sales by Application (2026-2031)
5.1.3 Global Vaccin Antirabic Sales Market Share by Application (2020-2031)
5.2 Global Vaccin Antirabic Revenue by Application (2020-2031)
5.2.1 Global Vaccin Antirabic Revenue by Application (2020-2025)
5.2.2 Global Vaccin Antirabic Revenue by Application (2026-2031)
5.2.3 Global Vaccin Antirabic Revenue Market Share by Application (2020-2031)
5.3 Global Vaccin Antirabic Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Vaccin Antirabic Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Vaccin Antirabic Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Vaccin Antirabic Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Vaccin Antirabic Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Chengda
6.3.1 Chengda Company Information
6.3.2 Chengda Description and Business Overview
6.3.3 Chengda Vaccin Antirabic Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Chengda Vaccin Antirabic Product Portfolio
6.3.5 Chengda Recent Developments/Updates
6.4 Yisheng
6.4.1 Yisheng Company Information
6.4.2 Yisheng Description and Business Overview
6.4.3 Yisheng Vaccin Antirabic Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Yisheng Vaccin Antirabic Product Portfolio
6.4.5 Yisheng Recent Developments/Updates
6.5 Merck
6.5.1 Merck Company Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Vaccin Antirabic Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck Vaccin Antirabic Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 VACN
6.6.1 VACN Company Information
6.6.2 VACN Description and Business Overview
6.6.3 VACN Vaccin Antirabic Sales, Revenue and Gross Margin (2020-2025)
6.6.4 VACN Vaccin Antirabic Product Portfolio
6.6.5 VACN Recent Developments/Updates
6.7 Changsheng
6.7.1 Changsheng Company Information
6.7.2 Changsheng Description and Business Overview
6.7.3 Changsheng Vaccin Antirabic Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Changsheng Vaccin Antirabic Product Portfolio
6.7.5 Changsheng Recent Developments/Updates
6.8 BCHT
6.8.1 BCHT Company Information
6.8.2 BCHT Description and Business Overview
6.8.3 BCHT Vaccin Antirabic Sales, Revenue and Gross Margin (2020-2025)
6.8.4 BCHT Vaccin Antirabic Product Portfolio
6.8.5 BCHT Recent Developments/Updates
6.9 Hissen
6.9.1 Hissen Company Information
6.9.2 Hissen Description and Business Overview
6.9.3 Hissen Vaccin Antirabic Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hissen Vaccin Antirabic Product Portfolio
6.9.5 Hissen Recent Developments/Updates
6.10 Zhongke Biological
6.10.1 Zhongke Biological Company Information
6.10.2 Zhongke Biological Description and Business Overview
6.10.3 Zhongke Biological Vaccin Antirabic Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Zhongke Biological Vaccin Antirabic Product Portfolio
6.10.5 Zhongke Biological Recent Developments/Updates
6.11 Ningbo Rongan Biological Pharmaceutical
6.11.1 Ningbo Rongan Biological Pharmaceutical Company Information
6.11.2 Ningbo Rongan Biological Pharmaceutical Description and Business Overview
6.11.3 Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Product Portfolio
6.11.5 Ningbo Rongan Biological Pharmaceutical Recent Developments/Updates
6.12 Guangzhou Nuocheng Biological
6.12.1 Guangzhou Nuocheng Biological Company Information
6.12.2 Guangzhou Nuocheng Biological Description and Business Overview
6.12.3 Guangzhou Nuocheng Biological Vaccin Antirabic Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Guangzhou Nuocheng Biological Vaccin Antirabic Product Portfolio
6.12.5 Guangzhou Nuocheng Biological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccin Antirabic Industry Chain Analysis
7.2 Vaccin Antirabic Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccin Antirabic Production Mode & Process Analysis
7.4 Vaccin Antirabic Sales and Marketing
7.4.1 Vaccin Antirabic Sales Channels
7.4.2 Vaccin Antirabic Distributors
7.5 Vaccin Antirabic Customer Analysis
8 Vaccin Antirabic Market Dynamics
8.1 Vaccin Antirabic Industry Trends
8.2 Vaccin Antirabic Market Drivers
8.3 Vaccin Antirabic Market Challenges
8.4 Vaccin Antirabic Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GSK
Sanofi
Chengda
Yisheng
Merck
VACN
Changsheng
BCHT
Hissen
Zhongke Biological
Ningbo Rongan Biological Pharmaceutical
Guangzhou Nuocheng Biological
List of Tables
 Table 1. Global Vaccin Antirabic Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Vaccin Antirabic Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Vaccin Antirabic Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Vaccin Antirabic Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Vaccin Antirabic Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Vaccin Antirabic Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Vaccin Antirabic Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Vaccin Antirabic Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Vaccin Antirabic, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Vaccin Antirabic, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Vaccin Antirabic, Product Type & Application
 Table 12. Global Key Manufacturers of Vaccin Antirabic, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Vaccin Antirabic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccin Antirabic as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Vaccin Antirabic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Vaccin Antirabic Sales by Region (2020-2025) & (K Units)
 Table 18. Global Vaccin Antirabic Sales Market Share by Region (2020-2025)
 Table 19. Global Vaccin Antirabic Sales by Region (2026-2031) & (K Units)
 Table 20. Global Vaccin Antirabic Sales Market Share by Region (2026-2031)
 Table 21. Global Vaccin Antirabic Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Vaccin Antirabic Revenue Market Share by Region (2020-2025)
 Table 23. Global Vaccin Antirabic Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Vaccin Antirabic Revenue Market Share by Region (2026-2031)
 Table 25. North America Vaccin Antirabic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Vaccin Antirabic Sales by Country (2020-2025) & (K Units)
 Table 27. North America Vaccin Antirabic Sales by Country (2026-2031) & (K Units)
 Table 28. North America Vaccin Antirabic Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Vaccin Antirabic Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Vaccin Antirabic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Vaccin Antirabic Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Vaccin Antirabic Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Vaccin Antirabic Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Vaccin Antirabic Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Vaccin Antirabic Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Vaccin Antirabic Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Vaccin Antirabic Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Vaccin Antirabic Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Vaccin Antirabic Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Vaccin Antirabic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Vaccin Antirabic Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Vaccin Antirabic Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Vaccin Antirabic Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Vaccin Antirabic Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Vaccin Antirabic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Vaccin Antirabic Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Vaccin Antirabic Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Vaccin Antirabic Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Vaccin Antirabic Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Vaccin Antirabic Sales (K Units) by Type (2020-2025)
 Table 51. Global Vaccin Antirabic Sales (K Units) by Type (2026-2031)
 Table 52. Global Vaccin Antirabic Sales Market Share by Type (2020-2025)
 Table 53. Global Vaccin Antirabic Sales Market Share by Type (2026-2031)
 Table 54. Global Vaccin Antirabic Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Vaccin Antirabic Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Vaccin Antirabic Revenue Market Share by Type (2020-2025)
 Table 57. Global Vaccin Antirabic Revenue Market Share by Type (2026-2031)
 Table 58. Global Vaccin Antirabic Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Vaccin Antirabic Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Vaccin Antirabic Sales (K Units) by Application (2020-2025)
 Table 61. Global Vaccin Antirabic Sales (K Units) by Application (2026-2031)
 Table 62. Global Vaccin Antirabic Sales Market Share by Application (2020-2025)
 Table 63. Global Vaccin Antirabic Sales Market Share by Application (2026-2031)
 Table 64. Global Vaccin Antirabic Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Vaccin Antirabic Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Vaccin Antirabic Revenue Market Share by Application (2020-2025)
 Table 67. Global Vaccin Antirabic Revenue Market Share by Application (2026-2031)
 Table 68. Global Vaccin Antirabic Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Vaccin Antirabic Price (US$/Unit) by Application (2026-2031)
 Table 70. GSK Company Information
 Table 71. GSK Description and Business Overview
 Table 72. GSK Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. GSK Vaccin Antirabic Product
 Table 74. GSK Recent Developments/Updates
 Table 75. Sanofi Company Information
 Table 76. Sanofi Description and Business Overview
 Table 77. Sanofi Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Sanofi Vaccin Antirabic Product
 Table 79. Sanofi Recent Developments/Updates
 Table 80. Chengda Company Information
 Table 81. Chengda Description and Business Overview
 Table 82. Chengda Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Chengda Vaccin Antirabic Product
 Table 84. Chengda Recent Developments/Updates
 Table 85. Yisheng Company Information
 Table 86. Yisheng Description and Business Overview
 Table 87. Yisheng Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Yisheng Vaccin Antirabic Product
 Table 89. Yisheng Recent Developments/Updates
 Table 90. Merck Company Information
 Table 91. Merck Description and Business Overview
 Table 92. Merck Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Merck Vaccin Antirabic Product
 Table 94. Merck Recent Developments/Updates
 Table 95. VACN Company Information
 Table 96. VACN Description and Business Overview
 Table 97. VACN Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. VACN Vaccin Antirabic Product
 Table 99. VACN Recent Developments/Updates
 Table 100. Changsheng Company Information
 Table 101. Changsheng Description and Business Overview
 Table 102. Changsheng Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Changsheng Vaccin Antirabic Product
 Table 104. Changsheng Recent Developments/Updates
 Table 105. BCHT Company Information
 Table 106. BCHT Description and Business Overview
 Table 107. BCHT Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. BCHT Vaccin Antirabic Product
 Table 109. BCHT Recent Developments/Updates
 Table 110. Hissen Company Information
 Table 111. Hissen Description and Business Overview
 Table 112. Hissen Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Hissen Vaccin Antirabic Product
 Table 114. Hissen Recent Developments/Updates
 Table 115. Zhongke Biological Company Information
 Table 116. Zhongke Biological Description and Business Overview
 Table 117. Zhongke Biological Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Zhongke Biological Vaccin Antirabic Product
 Table 119. Zhongke Biological Recent Developments/Updates
 Table 120. Ningbo Rongan Biological Pharmaceutical Company Information
 Table 121. Ningbo Rongan Biological Pharmaceutical Description and Business Overview
 Table 122. Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Product
 Table 124. Ningbo Rongan Biological Pharmaceutical Recent Developments/Updates
 Table 125. Guangzhou Nuocheng Biological Company Information
 Table 126. Guangzhou Nuocheng Biological Description and Business Overview
 Table 127. Guangzhou Nuocheng Biological Vaccin Antirabic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Guangzhou Nuocheng Biological Vaccin Antirabic Product
 Table 129. Guangzhou Nuocheng Biological Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Vaccin Antirabic Distributors List
 Table 133. Vaccin Antirabic Customers List
 Table 134. Vaccin Antirabic Market Trends
 Table 135. Vaccin Antirabic Market Drivers
 Table 136. Vaccin Antirabic Market Challenges
 Table 137. Vaccin Antirabic Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Vaccin Antirabic
 Figure 2. Global Vaccin Antirabic Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Vaccin Antirabic Market Share by Type: 2024 & 2031
 Figure 4. Gopher Kidney Cell Vaccine Product Picture
 Figure 5. Freeze-Dried Vero Cell Vaccine Product Picture
 Figure 6. Common Vero Cell Vaccines Product Picture
 Figure 7. Human Diploid Vaccine Product Picture
 Figure 8. Global Vaccin Antirabic Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Vaccin Antirabic Market Share by Application: 2024 & 2031
 Figure 10. Pre-exposure Prophylaxis
 Figure 11. After Exposure Prophylaxis
 Figure 12. Additional Doses
 Figure 13. Global Vaccin Antirabic Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Vaccin Antirabic Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Vaccin Antirabic Sales (2020-2031) & (K Units)
 Figure 16. Global Vaccin Antirabic Average Price (US$/Unit) & (2020-2031)
 Figure 17. Vaccin Antirabic Report Years Considered
 Figure 18. Vaccin Antirabic Sales Share by Manufacturers in 2024
 Figure 19. Global Vaccin Antirabic Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Vaccin Antirabic Players: Market Share by Revenue in Vaccin Antirabic in 2024
 Figure 21. Vaccin Antirabic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Vaccin Antirabic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Vaccin Antirabic Sales Market Share by Country (2020-2031)
 Figure 24. North America Vaccin Antirabic Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Vaccin Antirabic Sales Market Share by Country (2020-2031)
 Figure 28. Europe Vaccin Antirabic Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Vaccin Antirabic Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Vaccin Antirabic Revenue Market Share by Region (2020-2031)
 Figure 36. China Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Vaccin Antirabic Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Vaccin Antirabic Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Vaccin Antirabic Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Vaccin Antirabic Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Vaccin Antirabic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Vaccin Antirabic by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Vaccin Antirabic by Type (2020-2031)
 Figure 58. Global Vaccin Antirabic Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Vaccin Antirabic by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Vaccin Antirabic by Application (2020-2031)
 Figure 61. Global Vaccin Antirabic Price (US$/Unit) by Application (2020-2031)
 Figure 62. Vaccin Antirabic Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Rabies Vaccines for Animals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rabies Virus Vaccine for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Animal Anti Rabies Vaccine Market Research Report 2024
Freeze dried Human Rabies Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Rabies Serum Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Animal Rabies Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rabies Vaccination Market Research Report 2025
Rabies Vaccine Market
Human Diploid Cellular Rabies Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Attenuated Vaccine for Human Rabies Market Research Report 2025
Oral Rabies Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Animal Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rabies Vaccine for Pets Market Research Report 2024
Global Human Rabies Vaccination Market Research Report 2025
Global Rabies Diagnosis Market Research Report 2024
Global Human Rabies Vaccine Market Research Report 2024
Global Rabies Treatment Market Research Report 2024
VLP Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Preventable Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rinderpest Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions